Anti-CD20 Antibody (Obinutuzumab)
Catalog No.
F1372
Anti-CD20 Antibody (Obinutuzumab)
Featured Products
Obinutuzumab (GA101) is a novel glycoengineered class II CD20 humanized IgG1 monoclonal antibody for the study of non-Hodgkin's lymphoma.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.32 kDa
Dry ice
949142-50-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Gazyvaro, Gazyva, GA101
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P11836
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CD20 VLP at 2 ug/mL can bind Anti-CD20 Antibody (Obinutuzumab)
CD20
Please avoid freeze-thaw cycles.